Latest & greatest articles for insomnia

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on insomnia or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on insomnia and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for insomnia

561. Cost-effectiveness analysis of nocturnal oximetry as a method of screening for sleep apnea-hypopnea syndrome

-effectiveness analysis of nocturnal oximetry as a method of screening for sleep apnea-hypopnea syndrome. Chest 1998; 113(1): 97-103 PubMedID Other publications of related interest Series F, Marc I, Cormier Y, et al. Utility of nocturnal home oximetry for case finding in patients with suspected sleep apnea hypopnea syndrome. Annals of Internal Medicine 1993;119:449-53. Rodriguez J M, de Lucas P, Izquierdo J L, et al. Nocturnal oximetry in the screening of obstructive sleep apnea syndrome. Chest 1994;46:586 (...) Cost-effectiveness analysis of nocturnal oximetry as a method of screening for sleep apnea-hypopnea syndrome Cost-effectiveness analysis of nocturnal oximetry as a method of screening for sleep apnea-hypopnea syndrome Cost-effectiveness analysis of nocturnal oximetry as a method of screening for sleep apnea-hypopnea syndrome Epstein L J, Dorlac G R Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief

1998 NHS Economic Evaluation Database.

562. Benzodiazepines and zolpidem for chronic insomnia: a meta-analysis of treatment efficacy

Contents was also searched and references cited in reports were obtained. The search strategy used the subject heading 'insomnia' with the subheading 'drug therapy' combined with 'placebos'. The Journal of Sleep Research was handsearched up to 1995. Only published studies were included. Study selection Study designs of evaluations included in the review Randomised controlled trials (RCTs) that included placebo groups and double-blinded assessment of the outcomes. Crossover designs were included (...) heterogeneity. The post-treatment between-group comparisons of effect size were 0.56 (95% confidence interval, CI: 0.41, 0.71) for sleep-onset latency, 0.71 (95% CI: 0.55, 0.87) for total sleep time, 0.65 (95% CI: 0.48, 0.82) for the number of awakenings, and 0.62 (95% CI: 0.45, 0.79) for sleep quality. There were no well-controlled studies of long-term treatment. Authors' conclusions Benzodiazepines and zolpidem produced reliable improvements in sleep in patients with chronic insomnia. Relative

1997 DARE.

563. Should patients with sleep apnoea/hypopnoea syndrome be diagnosed and managed on the basis of home sleep studies

Should patients with sleep apnoea/hypopnoea syndrome be diagnosed and managed on the basis of home sleep studies Should patients with sleep apnoea/hypopnoea syndrome be diagnosed and managed on the basis of home sleep studies Should patients with sleep apnoea/hypopnoea syndrome be diagnosed and managed on the basis of home sleep studies Parra O, Garcia-Esclasans N, Montserrat J M, Eroles L G, Ruiz J, Lopez J A, Guerra J M, Sopena J J Record Status This is a critical abstract of an economic (...) evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology A portable monitor of respiratory parameters (PMRP) in a home setting versus full-polysomnography (full-PSG) in the sleep laboratory for the diagnosis of patients with suspected sleep apnoea/hypopnoea syndrome (SAHS). Type of intervention

1997 NHS Economic Evaluation Database.

564. A cost-effective and rational surgical approach to patients with snoring, upper airway resistance syndrome, or obstructive sleep apnea syndrome

A cost-effective and rational surgical approach to patients with snoring, upper airway resistance syndrome, or obstructive sleep apnea syndrome A cost-effective and rational surgical approach to patients with snoring, upper airway resistance syndrome, or obstructive sleep apnea syndrome A cost-effective and rational surgical approach to patients with snoring, upper airway resistance syndrome, or obstructive sleep apnea syndrome Utley D S, Shin E J, Clerk A A, Terris D J Record Status (...) This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Laser-assisted uvulopalatoplasty (LAUP) surgical approach to patients with snoring, upper airway resistance syndrome (UARS), or obstructive sleep apnea syndrome (OSAS). Type of intervention Secondary prevention

1997 NHS Economic Evaluation Database.

565. Effect of theophylline on sleep-disordered breathing in heart failure. (Abstract)

Effect of theophylline on sleep-disordered breathing in heart failure. Theophylline has been used to treat central apnea associated with Cheyne-Stokes respiration (periodic breathing). We studied the effect of short-term oral theophylline therapy on periodic breathing associated with stable heart failure due to systolic dysfunction.Fifteen men with compensated heart failure (left ventricular ejection fraction, 45 percent or less) participated in the study. Their base-line polysomnograms showed (...) periodic breathing, with more than 10 episodes of apnea and hypopnea per hour. In a double-blind crossover study, the patients received theophylline or placebo orally twice daily for five days, with one week of washout between the two periods.After five days of treatment, the mean (+/-SD) plasma theophylline concentration was 11 +/- 2 microgram per milliliter. Theophylline therapy resulted in significant decreases in the number of episodes of apnea and hypopnea per hour (18 +/- 17, vs. 37 +/- 23

1996 NEJM Controlled trial quality: uncertain

566. Screening for obstructive sleep apnea in patients presenting for snoring surgery

Screening for obstructive sleep apnea in patients presenting for snoring surgery Screening for obstructive sleep apnea in patients presenting for snoring surgery Screening for obstructive sleep apnea in patients presenting for snoring surgery Pradhan P S, Gliklich R E, Winkelman J Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed (...) by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Using clinical data alone or oximetry and clinical data in the screening to identify obstructive sleep apnea (OSA) in patients presenting for snoring surgery. Type of intervention Screening. Economic study type Cost-effectiveness analysis. Study population Patient presenting for snoring surgery. Setting Hospital. The economic study was carried out in Philadelphia, USA. Dates to which data relate

1996 NHS Economic Evaluation Database.

567. The efficacy of surgical modifications of the upper airway in adults with obstructive sleep apnea syndrome

The efficacy of surgical modifications of the upper airway in adults with obstructive sleep apnea syndrome The efficacy of surgical modifications of the upper airway in adults with obstructive sleep apnea syndrome The efficacy of surgical modifications of the upper airway in adults with obstructive sleep apnea syndrome Sher A E, Schechtman K B, Piccirillo J F Authors' objectives To review the efficacy of surgical modifications of the upper airway in treating adults with obstructive sleep apnoea (...) greater than 50. In a third series of 38 patients, excessive daytime sleepiness was resolved in all patients within 48 hours post-operatively. No data were given on the AI or RDI values. Authors' conclusions UPPP is at best effective in treating less than 50% of patients with obstructive sleep apnoea syndrome. The site of pharyngeal narrowing or collapse, although identified by different and unvalidated methods, has a marked effect on the probability of success of UPPP. Patients who achieve

1996 DARE.

568. Integration of Behavioral and Relaxation Approaches Into the Treatment of Chronic Pain and Insomnia

of the improvement in sleep onset and total sleep time is clinically significant. 1 Introduction Chronic pain and insomnia afflict millions of Americans. Despite the acknowledged importance of psychosocial and behavioral factors in these disorders, treatment strategies have tended to focus on bio­ medical interventions such as drugs and surgery. The purpose of this conference was to examine the usefulness of integrating behavioral and relaxation approaches with biomedical interventions in clinical and research (...) evaluation of a patient is empha­ sized in the field of insomnia where failure to identify a condition such as sleep apnea may result in inappropriate application of a behavioral therapy. Therapy should be matched to the illness and to the patient. Integration of psychosocial issues with conventional medical approaches will necessitate the application of new methodologies to assess the success or failure of the interventions. Therefore, additional barriers to integration include lack of standardization

1995 NIH Consensus Statements

569. Oral appliances for the treatment of snoring and obstructive sleep apnea: a review

Oral appliances for the treatment of snoring and obstructive sleep apnea: a review Oral appliances for the treatment of snoring and obstructive sleep apnea: a review Oral appliances for the treatment of snoring and obstructive sleep apnea: a review Schmidt-Nowara W, Lowe A, Wiegand L, Cartwright R, Perez-Guerra F, Menn S Authors' objectives To evaluate the effectiveness of oral appliances for the treatment of snoring and obstructive sleep apnoea (OSA). Searching MEDLINE was searched from 1966 (...) advancement device (MAD), tongue-retaining device (TRD) and nocturnal airway patency device (NAPA). Participants included in the review Adults with OSA; predominantly male, middle-aged and overweight, where diagnosis of OSA was validated with polysomnography in all but one study. Outcomes assessed in the review Percentage improvement in snoring (Apnea-Hypopnea Index, AHI), sleep apnoea improvement, sleep, sleepiness and side-effects. How were decisions on the relevance of primary studies made? The authors

1995 DARE.

570. Identifying effective psychological treatments for insomnia: a meta-analysis

outcome. Bibliographic details Murtagh D R, Greenwood K M. Identifying effective psychological treatments for insomnia: a meta-analysis. Journal of Consulting and Clinical Psychology 1995; 63(1): 79-89 PubMedID Indexing Status Subject indexing assigned by NLM MeSH Adolescent; Adult; Aged; Female; Follow-Up Studies; Humans; Male; Middle Aged; Relaxation Therapy; Sleep Initiation and Maintenance Disorders /psychology /therapy; Treatment Outcome; Wakefulness AccessionNumber 11995005023 Date bibliographic (...) participants (e.g. prisoners or alcoholics) and insomniacs clinically-diagnosed with other sleep disorders, psychological disturbances or serious medical illness. Outcomes assessed in the review The outcomes assessed were SOL, TST, number of nocturnal awakenings and subjective evaluation of sleep quality. These variables were measured using sleep diary data since there was an insufficient number of groups using objective physiological or observer measures of sleep patterns. Short-term (within 3 months

1995 DARE.

571. Systematic review on obstructive sleep apnoea: its effect on health and benefit of treatment

Indexing Status Subject indexing assigned by CRD MeSH Airway Obstruction /physiopathology; Pharyngeal Diseases /pathology /physiopathology; Positive-Pressure Respiration; Pulmonary Ventilation /physiology; Sleep Apnea Syndromes /physiopathology /therapy; Sleep Wake Disorders /therapy /prevention & control AccessionNumber 11996008233 Date bibliographic record published 31/10/1996 Date abstract record published 31/10/1996 Record Status This is a critical abstract of a systematic review that meets (...) Systematic review on obstructive sleep apnoea: its effect on health and benefit of treatment Systematic review on obstructive sleep apnoea: its effect on health and benefit of treatment Systematic review on obstructive sleep apnoea: its effect on health and benefit of treatment Wright J, Dye R Authors' objectives To assess the evidence for effectiveness of treatment of obstructive sleep apnoea with continuous positive airways pressure. Searching MEDLINE was searched from 1966 to 1995

1995 DARE.

572. Effect of continuous positive airway pressure treatment on daytime function in sleep apnoea/hypopnoea syndrome. (Abstract)

Effect of continuous positive airway pressure treatment on daytime function in sleep apnoea/hypopnoea syndrome. Continuous positive airway pressure (CPAP) is the treatment of choice for the sleep apnoea/hypopnoea syndrome (SAHS); it is usually given with the aim of improving daytime cognitive function, mood, and sleepiness. However, its efficacy has not been validated by controlled trials. We have carried out a randomised, placebo-controlled, crossover study of objective daytime sleepiness (...) , symptoms, cognitive function, and mood in a consecutive series of 32 SAHS patients with a median apnoea plus hypopnoea frequency of 28 (range 7-129) per hour slept. Patients were treated with 4 weeks each of CPAP and an oral placebo, which they were told might improve upper airway muscle function during sleep. Assessments on the last day of each treatment included a multiple sleep latency test and tests of symptom scores, mood profiles, and cognitive performance. The patients had significantly less

1994 Lancet Controlled trial quality: uncertain

573. Evaluation of the application of nocturnal nasal continuous positive airway pressure (CPAP) in the treatment of obstructive sleep apnea

is recommended for obstructive sleep apnea syndrome only when the diagnosis is confirmed by nocturnal polygraphic or poly omnographic examination. Compliance with treatment must be assessed by the prescriber. Further research is required concerning the natural history of the disease and the influence of treatment on its course and simpler diagnostic tests need to be developed. Project page URL Indexing Status Subject indexing assigned by CRD MeSH Positive-Pressure Respiration; Sleep Apnea Syndromes Language (...) Evaluation of the application of nocturnal nasal continuous positive airway pressure (CPAP) in the treatment of obstructive sleep apnea Evaluation of the application of nocturnal nasal continuous positive airway pressure (CPAP) in the treatment of obstructive sleep apnea Evaluation of the application of nocturnal nasal continuous positive airway pressure (CPAP) in the treatment of obstructive sleep apnea Roche N, Durieux P Record Status This is a bibliographic record of a published health

1992 Health Technology Assessment (HTA) Database.

574. Effect of gradual withdrawal on the rebound sleep disorder after discontinuation of triazolam. (Abstract)

Effect of gradual withdrawal on the rebound sleep disorder after discontinuation of triazolam. Sixty volunteers with insomnia participated in a randomized, double-blind, controlled clinical trial. After an initial six nights of placebo, 30 subjects (the abrupt-withdrawal group) received 0.5 mg of triazolam nightly for 7 to 10 nights, after which they received placebo. The other 30 subjects (the tapered-dosage group) received the same initial placebo treatment, then triazolam at 0.5 mg for seven (...) , and subjects reported prolongation of sleep latency (57 minutes longer than base line), reduction in sleep duration (1.4 hours less than base line), and increased awakenings (1.2 per night above base line). The symptoms of rebound sleep disorder lasted one or possibly two nights, and there was a reversion toward base line on subsequent placebo nights. In the tapered-dosage group, however, plasma triazolam levels fell gradually to zero, and rebound symptoms were decreased or eliminated. Thus, rebound sleep

1987 NEJM Controlled trial quality: uncertain

575. Protriptyline in obstructive sleep apnea: a double-blind trial. (Abstract)

, and arousal frequency were decreased at this time. Although the obstructive sleep apnea was not resolved, it was reduced. Protriptyline can be effective in patients with sleep apnea when the disorder is not life-threatening. (...) Protriptyline in obstructive sleep apnea: a double-blind trial. We evaluated protriptyline, a nonsedating tricyclic antidepressant, as a treatment for obstructive sleep apnea in a double-blind crossover study of five men. After two weeks of treatment, with no change in body weight, daytime somnolence was markedly reduced and nocturnal oxygenation was improved, although apnea duration and frequency were not significantly decreased. Rapid-eye-movement (REM) stage time as a fraction of the total

1982 NEJM Controlled trial quality: uncertain